Talk Choice is the national campaign all about contraceptive choice, developed by healthcare company Organon, a part of Schering-Plough Corporation. It aims to inform and educate women about the full range of contraceptive options available to them. Our aim is that, along with their healthcare professionals, women are able to choose a suitable method that works with their body and lifestyle. Organon, a part of Schering-Plough Corporation supports a woman's right to choose her contraception from the full range of options available.
Getting the method right is important. If contraception doesn't fit with a woman's lifestyle it might not be used properly, increasing the risk of unplanned pregnancy. Around half of pregnancies in the UK are still unplanned despite over three quarters of women under 50 using some form of contraception.
The Talk Choice mission mirrors current national guidelines that recommend women requiring contraception should be given information about and given a choice of all contraceptive methods, including long-acting reversible contraception (LARC) methods (including the intrauterine device (IUD), hormonal injection, intrauterine system (IUS) and contraceptive implant).
“Contraception is a normal part of modern life but it isn't being given the time and attention it deserves. We need to start talking about and offering choice so that women have a method that suits their lifestyle and are effectively protected against unplanned pregnancy.”
Dr Anne Szarewski, Associate Specialist in Family Planning at The Margaret Pyke Centre
Information on this page has been sourced from a peer-reviewed scientific journal, Office for National Statistics and NICE.